Jenoptik AG/€JEN
1D1W1MYTD1Y5YMAX
Capital at risk
About Jenoptik AG
Jenoptik AG is a global technology group specializing in photonics, with core operations in the Advanced Photonic Solutions and Smart Mobility Solutions divisions. The company offers products and services in areas such as semiconductor and electronics, life science and medical technology, and smart mobility. Founded in 1991, Jenoptik traces its origins to the Carl Zeiss AG company established in Jena, Germany, in 1846. Headquartered in Jena, the company employs approximately 4,600 people worldwide. Jenoptik's strategic focus includes photonic growth markets, aiming to develop into a globally positioned photonics company. (,)
- Ticker
- €JEN
- Sector
- Digital Hardware
- Primary listing
- XETRA
- Employees
- 3,975
- Headquarters
- Jena, Germany
- Website
- www.jenoptik.com
Jenoptik AG Metrics
BasicAdvanced
€2.2B
24.82
€1.53
1.22
€0.40
1.06%
Price and volume
Market cap
€2.2B
Beta
1.22
52-week high
€48.48
52-week low
€16.32
Average daily volume
122K
Dividend rate
€0.40
Financial strength
Current ratio
2.399
Quick ratio
1.276
Long term debt to equity
0.401
Total debt to equity
0.424
Dividend payout ratio (TTM)
26.22%
Interest coverage (TTM)
6.50%
Profitability
EBITDA (TTM)
197.429
Gross margin (TTM)
34.49%
Net profit margin (TTM)
8.31%
Operating margin (TTM)
13.11%
Effective tax rate (TTM)
28.88%
Revenue per employee (TTM)
€260,000
Management effectiveness
Return on assets (TTM)
5.04%
Return on equity (TTM)
8.85%
Valuation
Price to earnings (TTM)
24.817
Price to revenue (TTM)
2.062
Price to book
2.1
Price to tangible book (TTM)
5.6
Price to free cash flow (TTM)
16.238
Free cash flow yield (TTM)
6.16%
Free cash flow per share (TTM)
2.332
Dividend yield (TTM)
1.06%
Forward dividend yield
1.06%
Growth
Revenue change (TTM)
-2.11%
Earnings per share change (TTM)
12.80%
3-year revenue growth (CAGR)
0.40%
10-year revenue growth (CAGR)
4.46%
3-year earnings per share growth (CAGR)
11.07%
10-year earnings per share growth (CAGR)
5.36%
3-year dividend per share growth (CAGR)
10.06%
10-year dividend per share growth (CAGR)
6.16%
Bulls say / Bears say
Order momentum is exceptionally strong: first-half 2026 order intake increased 53.0% to €723.4 million, book-to-bill reached 1.44, and the order backlog rose to €824.8 million from €590.8 million at year-end 2025. (Jenoptik)
Profitability has improved materially: first-half EBITDA increased 25.5% to €98.9 million, lifting the EBITDA margin to 19.7% from 15.8%, while free cash flow before interest and taxes rose to €47.2 million. (Jenoptik)
Semiconductor exposure is producing strong growth and management has raised confidence in 2026: Semiconductor & Advanced Manufacturing revenue rose 10.2%, its order intake increased 85.3%, and full-year revenue and EBITDA-margin expectations were refined to the upper half of prior ranges. (Jenoptik)
Revenue growth remains modest despite stronger orders: first-half 2026 revenue rose just 1.0% year over year, while Biophotonics declined 4.5% and Metrology & Production Solutions fell to €79.7 million from €92.0 million amid continued automotive weakness. (Jenoptik)
The sharp order momentum may prove difficult to sustain: management said the first-half improvement was partly driven by several major orders and that the unusually strong dynamic is unlikely to continue in the second half. (Jenoptik)
Jenoptik remains exposed to macroeconomic and political uncertainty, with its 2026 guidance conditional on those conditions not deteriorating; the company also implemented a new CEO and reorganized executive responsibilities from August 1, creating near-term execution risk. (Jenoptik)
Data summarised monthly by Lightyear AI. Last updated on 14 Sept 2026.
Upcoming events
No upcoming events
Funds containing Jenoptik AG
AllEURGBPUSD
Fund name | Fund size | €JEN weighting |
|---|---|---|
iShares TecDAX€EXS2 | €645M | 1.63% |
iShares MDAX€EXID | €34M | 1.34% |
iShares MDAX€EXS3 | €1.5B | 1.15% |
Xtrackers MSCI Europe Small Cap€DX2J | €3.2B | 0.16% |
Xtrackers MSCI Europe Small Cap£XXSC | £2.8B | 0.16% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.